Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes-Reference-Cited by-同舟云学术

Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes

Published:2016-04 Issue:4 Volume:34 Page:781-787
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Hirakawa Yoichiro,Arima Hisatomi,Webster Ruth,Zoungas Sophia,Li Qiang,Harrap Stephen,Lisheng Liu,Hamet Pavel,Mancia Giuseppe,Poulter Neil,Neal Bruce,Williams Bryan,Rogers Anthony,Woodward Mark,Chalmers John

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference27 articles.

1. Nonadherence to cardiovascular medications.;Kolandaivelu;Eur Heart J,2014

2. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.;Mazzaglia;Circulation,2009

3. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.;Granger;Lancet,2005

4. Treatment adherence and risk of death after a myocardial infarction.;Horwitz;Lancet,1990

5. The relationship of treatment adherence to the risk of death after myocardial infarction in women.;Gallagher;JAMA,1993

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination blood pressure lowering therapy in patients with type 2 diabetes: messages from the ADVANCE trial;Journal of Hypertension;2024-08-27

2. Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines;Hypertension;2024-05

3. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension;Journal of Hypertension;2023-09-26

4. Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials;Journal of Hypertension;2023-01-19

5. Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension;Journal of the American Heart Association;2022-09-06